PubRank

Aynur Unalp

Author PubWeight™ 35.64‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med 2010 13.33
2 Hedgehog pathway activation parallels histologic severity of injury and fibrosis in human nonalcoholic fatty liver disease. Hepatology 2012 2.93
3 Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network. Hepatology 2009 2.78
4 Smoking and severity of hepatic fibrosis in nonalcoholic fatty liver disease. J Hepatol 2010 2.42
5 Pioglitazone versus vitamin E versus placebo for the treatment of non-diabetic patients with non-alcoholic steatohepatitis: PIVENS trial design. Contemp Clin Trials 2008 2.17
6 Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis. Hepatology 2012 2.10
7 Correlation of vitamin E, uric acid, and diet composition with histologic features of pediatric NAFLD. J Pediatr Gastroenterol Nutr 2012 1.82
8 Relationship of steatosis grade and zonal location to histological features of steatohepatitis in adult patients with non-alcoholic fatty liver disease. J Hepatol 2008 1.67
9 Treatment of nonalcoholic fatty liver disease in children: TONIC trial design. Contemp Clin Trials 2009 1.48
10 Quality of life in adults with nonalcoholic fatty liver disease: baseline data from the nonalcoholic steatohepatitis clinical research network. Hepatology 2009 1.26
11 Influence of local reference populations on upper limits of normal for serum alanine aminotransferase levels. Arch Intern Med 2008 1.25
12 Effects of liver biopsy sample length and number of readings on sampling variability in nonalcoholic Fatty liver disease. Clin Gastroenterol Hepatol 2008 1.08
13 Generalizability of the nonalcoholic steatohepatitis Clinical Research Network histologic scoring system for nonalcoholic fatty liver disease. J Clin Gastroenterol 2011 1.02
14 Coffee consumption in NAFLD patients with lower insulin resistance is associated with lower risk of severe fibrosis. Liver Int 2013 0.97